nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorzoxazone—CYP2E1—type 2 diabetes mellitus	0.171	0.387	CbGaD
Chlorzoxazone—CYP1A2—type 2 diabetes mellitus	0.163	0.369	CbGaD
Chlorzoxazone—CYP3A4—type 2 diabetes mellitus	0.108	0.244	CbGaD
Chlorzoxazone—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0671	0.181	CbGbCtD
Chlorzoxazone—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0256	0.069	CbGbCtD
Chlorzoxazone—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0229	0.0616	CbGbCtD
Chlorzoxazone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0226	0.0608	CbGbCtD
Chlorzoxazone—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0211	0.0569	CbGbCtD
Chlorzoxazone—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0202	0.0544	CbGbCtD
Chlorzoxazone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0201	0.0542	CbGbCtD
Chlorzoxazone—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0191	0.0514	CbGbCtD
Chlorzoxazone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0184	0.0496	CbGbCtD
Chlorzoxazone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0173	0.0467	CbGbCtD
Chlorzoxazone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0166	0.0448	CbGbCtD
Chlorzoxazone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0161	0.0433	CbGbCtD
Chlorzoxazone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0145	0.0392	CbGbCtD
Chlorzoxazone—CYP1A2—Losartan—type 2 diabetes mellitus	0.013	0.035	CbGbCtD
Chlorzoxazone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.011	0.0297	CbGbCtD
Chlorzoxazone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0106	0.0285	CbGbCtD
Chlorzoxazone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0106	0.0285	CbGbCtD
Chlorzoxazone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00999	0.0269	CbGbCtD
Chlorzoxazone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00744	0.0201	CbGbCtD
Chlorzoxazone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00681	0.0184	CbGbCtD
Chlorzoxazone—Digestion impaired—Tolbutamide—type 2 diabetes mellitus	0.004	0.0376	CcSEcCtD
Chlorzoxazone—Digestion impaired—Tolazamide—type 2 diabetes mellitus	0.00364	0.0342	CcSEcCtD
Chlorzoxazone—Digestion impaired—Chlorpropamide—type 2 diabetes mellitus	0.00364	0.0342	CcSEcCtD
Chlorzoxazone—Chromaturia—Irbesartan—type 2 diabetes mellitus	0.00247	0.0232	CcSEcCtD
Chlorzoxazone—Digestion impaired—Glipizide—type 2 diabetes mellitus	0.00242	0.0227	CcSEcCtD
Chlorzoxazone—Digestion impaired—Glyburide—type 2 diabetes mellitus	0.00186	0.0175	CcSEcCtD
Chlorzoxazone—Digestion impaired—Gliclazide—type 2 diabetes mellitus	0.00167	0.0157	CcSEcCtD
Chlorzoxazone—Lightheadedness—Bromocriptine—type 2 diabetes mellitus	0.00122	0.0114	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Glipizide—type 2 diabetes mellitus	0.00117	0.011	CcSEcCtD
Chlorzoxazone—Digestion impaired—Ramipril—type 2 diabetes mellitus	0.00106	0.00998	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Tolazamide—type 2 diabetes mellitus	0.000988	0.00927	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Bromocriptine—type 2 diabetes mellitus	0.000987	0.00926	CcSEcCtD
Chlorzoxazone—Angioedema—Linagliptin—type 2 diabetes mellitus	0.000962	0.00903	CcSEcCtD
Chlorzoxazone—Malaise—Tolazamide—type 2 diabetes mellitus	0.00096	0.00901	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Miglitol—type 2 diabetes mellitus	0.000917	0.0086	CcSEcCtD
Chlorzoxazone—Drowsiness—Glipizide—type 2 diabetes mellitus	0.000904	0.00848	CcSEcCtD
Chlorzoxazone—Discomfort—Tolazamide—type 2 diabetes mellitus	0.000895	0.0084	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.00086	0.00807	CcSEcCtD
Chlorzoxazone—Drowsiness—Glimepiride—type 2 diabetes mellitus	0.000843	0.00791	CcSEcCtD
Chlorzoxazone—Dyspepsia—Tolbutamide—type 2 diabetes mellitus	0.00084	0.00789	CcSEcCtD
Chlorzoxazone—Lightheadedness—Metformin—type 2 diabetes mellitus	0.000836	0.00784	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Tolbutamide—type 2 diabetes mellitus	0.000824	0.00774	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Gliclazide—type 2 diabetes mellitus	0.00081	0.0076	CcSEcCtD
Chlorzoxazone—Ecchymosis—Irbesartan—type 2 diabetes mellitus	0.000797	0.00748	CcSEcCtD
Chlorzoxazone—Lightheadedness—Irbesartan—type 2 diabetes mellitus	0.000789	0.0074	CcSEcCtD
Chlorzoxazone—Dyspepsia—Tolazamide—type 2 diabetes mellitus	0.000765	0.00718	CcSEcCtD
Chlorzoxazone—Dyspepsia—Chlorpropamide—type 2 diabetes mellitus	0.000765	0.00718	CcSEcCtD
Chlorzoxazone—Drowsiness—Bromocriptine—type 2 diabetes mellitus	0.000761	0.00714	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Tolazamide—type 2 diabetes mellitus	0.00075	0.00704	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Chlorpropamide—type 2 diabetes mellitus	0.00075	0.00704	CcSEcCtD
Chlorzoxazone—Ecchymosis—Losartan—type 2 diabetes mellitus	0.00075	0.00704	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Linagliptin—type 2 diabetes mellitus	0.000742	0.00696	CcSEcCtD
Chlorzoxazone—Angioedema—Rosiglitazone—type 2 diabetes mellitus	0.000737	0.00692	CcSEcCtD
Chlorzoxazone—Dyspepsia—Acarbose—type 2 diabetes mellitus	0.000735	0.00689	CcSEcCtD
Chlorzoxazone—KCNMA1—artery—type 2 diabetes mellitus	0.000733	0.2	CbGeAlD
Chlorzoxazone—Gastrointestinal disorder—Acarbose—type 2 diabetes mellitus	0.000721	0.00676	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Tolazamide—type 2 diabetes mellitus	0.000716	0.00672	CcSEcCtD
Chlorzoxazone—Dyspepsia—Nateglinide—type 2 diabetes mellitus	0.000708	0.00665	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.000697	0.00654	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Nateglinide—type 2 diabetes mellitus	0.000695	0.00652	CcSEcCtD
Chlorzoxazone—Rash—Miglitol—type 2 diabetes mellitus	0.00067	0.00628	CcSEcCtD
Chlorzoxazone—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000669	0.00628	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.000658	0.00618	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Glipizide—type 2 diabetes mellitus	0.000655	0.00615	CcSEcCtD
Chlorzoxazone—Malaise—Glipizide—type 2 diabetes mellitus	0.000637	0.00598	CcSEcCtD
Chlorzoxazone—Lightheadedness—Ramipril—type 2 diabetes mellitus	0.000636	0.00597	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Pioglitazone—type 2 diabetes mellitus	0.000628	0.00589	CcSEcCtD
Chlorzoxazone—Drowsiness—Gliclazide—type 2 diabetes mellitus	0.000624	0.00586	CcSEcCtD
Chlorzoxazone—Angioedema—Pioglitazone—type 2 diabetes mellitus	0.000618	0.0058	CcSEcCtD
Chlorzoxazone—Dyspepsia—Repaglinide—type 2 diabetes mellitus	0.000613	0.00575	CcSEcCtD
Chlorzoxazone—Malaise—Pioglitazone—type 2 diabetes mellitus	0.00061	0.00572	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Sitagliptin—type 2 diabetes mellitus	0.000609	0.00572	CcSEcCtD
Chlorzoxazone—Angioedema—Glimepiride—type 2 diabetes mellitus	0.000602	0.00565	CcSEcCtD
Chlorzoxazone—Rash—Tolbutamide—type 2 diabetes mellitus	0.000602	0.00565	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	0.000601	0.00564	CcSEcCtD
Chlorzoxazone—Angioedema—Sitagliptin—type 2 diabetes mellitus	0.0006	0.00563	CcSEcCtD
Chlorzoxazone—Discomfort—Glipizide—type 2 diabetes mellitus	0.000594	0.00557	CcSEcCtD
Chlorzoxazone—Malaise—Sitagliptin—type 2 diabetes mellitus	0.000592	0.00556	CcSEcCtD
Chlorzoxazone—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000574	0.00539	CcSEcCtD
Chlorzoxazone—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000574	0.00539	CcSEcCtD
Chlorzoxazone—Discomfort—Pioglitazone—type 2 diabetes mellitus	0.000569	0.00534	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.000568	0.00533	CcSEcCtD
Chlorzoxazone—Discomfort—Sitagliptin—type 2 diabetes mellitus	0.000553	0.00518	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.000552	0.00518	CcSEcCtD
Chlorzoxazone—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000548	0.00514	CcSEcCtD
Chlorzoxazone—Rash—Tolazamide—type 2 diabetes mellitus	0.000548	0.00514	CcSEcCtD
Chlorzoxazone—Rash—Linagliptin—type 2 diabetes mellitus	0.000542	0.00509	CcSEcCtD
Chlorzoxazone—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000542	0.00508	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000538	0.00505	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000536	0.00503	CcSEcCtD
Chlorzoxazone—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000532	0.00499	CcSEcCtD
Chlorzoxazone—Rash—Acarbose—type 2 diabetes mellitus	0.000526	0.00494	CcSEcCtD
Chlorzoxazone—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000526	0.00493	CcSEcCtD
Chlorzoxazone—Drowsiness—Metformin—type 2 diabetes mellitus	0.000522	0.0049	CcSEcCtD
Chlorzoxazone—Somnolence—Glipizide—type 2 diabetes mellitus	0.000512	0.00481	CcSEcCtD
Chlorzoxazone—Rash—Nateglinide—type 2 diabetes mellitus	0.000507	0.00476	CcSEcCtD
Chlorzoxazone—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.000507	0.00476	CcSEcCtD
Chlorzoxazone—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000507	0.00476	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000498	0.00467	CcSEcCtD
Chlorzoxazone—Angioedema—Glyburide—type 2 diabetes mellitus	0.000497	0.00466	CcSEcCtD
Chlorzoxazone—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000478	0.00449	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000477	0.00447	CcSEcCtD
Chlorzoxazone—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000477	0.00447	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000475	0.00446	CcSEcCtD
Chlorzoxazone—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000473	0.00444	CcSEcCtD
Chlorzoxazone—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000472	0.00443	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000464	0.00436	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000463	0.00434	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000455	0.00427	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.000453	0.00425	CcSEcCtD
Chlorzoxazone—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000446	0.00418	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000443	0.00416	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000442	0.00415	CcSEcCtD
Chlorzoxazone—Malaise—Gliclazide—type 2 diabetes mellitus	0.00044	0.00413	CcSEcCtD
Chlorzoxazone—Rash—Repaglinide—type 2 diabetes mellitus	0.000439	0.00412	CcSEcCtD
Chlorzoxazone—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000439	0.00412	CcSEcCtD
Chlorzoxazone—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000435	0.00408	CcSEcCtD
Chlorzoxazone—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000431	0.00405	CcSEcCtD
Chlorzoxazone—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000427	0.00401	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000419	0.00393	CcSEcCtD
Chlorzoxazone—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000415	0.00389	CcSEcCtD
Chlorzoxazone—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000415	0.00389	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000411	0.00386	CcSEcCtD
Chlorzoxazone—Discomfort—Gliclazide—type 2 diabetes mellitus	0.00041	0.00385	CcSEcCtD
Chlorzoxazone—Angioedema—Valsartan—type 2 diabetes mellitus	0.00041	0.00384	CcSEcCtD
Chlorzoxazone—Angioedema—Orlistat—type 2 diabetes mellitus	0.000405	0.0038	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.0004	0.00375	CcSEcCtD
Chlorzoxazone—Malaise—Orlistat—type 2 diabetes mellitus	0.000399	0.00375	CcSEcCtD
Chlorzoxazone—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00039	0.00366	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000383	0.00359	CcSEcCtD
Chlorzoxazone—Dizziness—Glipizide—type 2 diabetes mellitus	0.000381	0.00358	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000379	0.00355	CcSEcCtD
Chlorzoxazone—Discomfort—Orlistat—type 2 diabetes mellitus	0.000373	0.0035	CcSEcCtD
Chlorzoxazone—Malaise—Metformin—type 2 diabetes mellitus	0.000368	0.00345	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000366	0.00343	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000365	0.00343	CcSEcCtD
Chlorzoxazone—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000365	0.00343	CcSEcCtD
Chlorzoxazone—Rash—Glipizide—type 2 diabetes mellitus	0.000363	0.00341	CcSEcCtD
Chlorzoxazone—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000363	0.00341	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000362	0.00339	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000357	0.00335	CcSEcCtD
Chlorzoxazone—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000356	0.00334	CcSEcCtD
Chlorzoxazone—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000355	0.00333	CcSEcCtD
Chlorzoxazone—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000354	0.00332	CcSEcCtD
Chlorzoxazone—KCNMA1—islet of Langerhans—type 2 diabetes mellitus	0.000352	0.0963	CbGeAlD
Chlorzoxazone—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000352	0.0033	CcSEcCtD
Chlorzoxazone—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000351	0.00329	CcSEcCtD
Chlorzoxazone—Malaise—Irbesartan—type 2 diabetes mellitus	0.000347	0.00326	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000344	0.00323	CcSEcCtD
Chlorzoxazone—Discomfort—Metformin—type 2 diabetes mellitus	0.000343	0.00322	CcSEcCtD
Chlorzoxazone—Rash—Glimepiride—type 2 diabetes mellitus	0.000339	0.00318	CcSEcCtD
Chlorzoxazone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000339	0.00318	CcSEcCtD
Chlorzoxazone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000338	0.00317	CcSEcCtD
Chlorzoxazone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000338	0.00317	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000336	0.00316	CcSEcCtD
Chlorzoxazone—Angioedema—Losartan—type 2 diabetes mellitus	0.000331	0.00311	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000328	0.00308	CcSEcCtD
Chlorzoxazone—Malaise—Losartan—type 2 diabetes mellitus	0.000327	0.00307	CcSEcCtD
Chlorzoxazone—Somnolence—Valsartan—type 2 diabetes mellitus	0.000325	0.00305	CcSEcCtD
Chlorzoxazone—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000324	0.00304	CcSEcCtD
Chlorzoxazone—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000322	0.00302	CcSEcCtD
Chlorzoxazone—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000321	0.00301	CcSEcCtD
Chlorzoxazone—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000318	0.00299	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000316	0.00296	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000314	0.00295	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000312	0.00293	CcSEcCtD
Chlorzoxazone—Rash—Bromocriptine—type 2 diabetes mellitus	0.000306	0.00287	CcSEcCtD
Chlorzoxazone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000306	0.00287	CcSEcCtD
Chlorzoxazone—Discomfort—Losartan—type 2 diabetes mellitus	0.000305	0.00286	CcSEcCtD
Chlorzoxazone—KCNMA1—retina—type 2 diabetes mellitus	0.000301	0.0823	CbGeAlD
Chlorzoxazone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000298	0.0028	CcSEcCtD
Chlorzoxazone—Somnolence—Metformin—type 2 diabetes mellitus	0.000296	0.00278	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000296	0.00278	CcSEcCtD
Chlorzoxazone—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000293	0.00275	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000288	0.00271	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000288	0.0027	CcSEcCtD
Chlorzoxazone—Angioedema—Ramipril—type 2 diabetes mellitus	0.000284	0.00267	CcSEcCtD
Chlorzoxazone—Malaise—Ramipril—type 2 diabetes mellitus	0.00028	0.00263	CcSEcCtD
Chlorzoxazone—Rash—Glyburide—type 2 diabetes mellitus	0.00028	0.00262	CcSEcCtD
Chlorzoxazone—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00028	0.00262	CcSEcCtD
Chlorzoxazone—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000279	0.00262	CcSEcCtD
Chlorzoxazone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000277	0.0026	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000275	0.00258	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000271	0.00255	CcSEcCtD
Chlorzoxazone—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000263	0.00247	CcSEcCtD
Chlorzoxazone—Somnolence—Losartan—type 2 diabetes mellitus	0.000263	0.00247	CcSEcCtD
Chlorzoxazone—Discomfort—Ramipril—type 2 diabetes mellitus	0.000262	0.00245	CcSEcCtD
Chlorzoxazone—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00026	0.00244	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000259	0.00243	CcSEcCtD
Chlorzoxazone—KCNMA1—cardiovascular system—type 2 diabetes mellitus	0.000255	0.0696	CbGeAlD
Chlorzoxazone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000254	0.00238	CcSEcCtD
Chlorzoxazone—Rash—Gliclazide—type 2 diabetes mellitus	0.000251	0.00236	CcSEcCtD
Chlorzoxazone—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000251	0.00235	CcSEcCtD
Chlorzoxazone—KCNMA1—pancreas—type 2 diabetes mellitus	0.000248	0.0677	CbGeAlD
Chlorzoxazone—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000244	0.00229	CcSEcCtD
Chlorzoxazone—Dizziness—Valsartan—type 2 diabetes mellitus	0.000242	0.00227	CcSEcCtD
Chlorzoxazone—Dizziness—Orlistat—type 2 diabetes mellitus	0.000239	0.00224	CcSEcCtD
Chlorzoxazone—Rash—Valsartan—type 2 diabetes mellitus	0.000231	0.00216	CcSEcCtD
Chlorzoxazone—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00023	0.00216	CcSEcCtD
Chlorzoxazone—Rash—Orlistat—type 2 diabetes mellitus	0.000228	0.00214	CcSEcCtD
Chlorzoxazone—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000228	0.00214	CcSEcCtD
Chlorzoxazone—Somnolence—Ramipril—type 2 diabetes mellitus	0.000226	0.00212	CcSEcCtD
Chlorzoxazone—KCNMA1—adipose tissue—type 2 diabetes mellitus	0.000225	0.0614	CbGeAlD
Chlorzoxazone—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000223	0.0021	CcSEcCtD
Chlorzoxazone—Dizziness—Metformin—type 2 diabetes mellitus	0.00022	0.00207	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000219	0.00206	CcSEcCtD
Chlorzoxazone—Rash—Metformin—type 2 diabetes mellitus	0.00021	0.00197	CcSEcCtD
Chlorzoxazone—Dermatitis—Metformin—type 2 diabetes mellitus	0.00021	0.00197	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000209	0.00196	CcSEcCtD
Chlorzoxazone—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000208	0.00195	CcSEcCtD
Chlorzoxazone—Rash—Irbesartan—type 2 diabetes mellitus	0.000198	0.00186	CcSEcCtD
Chlorzoxazone—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000198	0.00186	CcSEcCtD
Chlorzoxazone—Dizziness—Losartan—type 2 diabetes mellitus	0.000196	0.00184	CcSEcCtD
Chlorzoxazone—CYP2A6—adipose tissue—type 2 diabetes mellitus	0.000188	0.0513	CbGeAlD
Chlorzoxazone—Rash—Losartan—type 2 diabetes mellitus	0.000187	0.00175	CcSEcCtD
Chlorzoxazone—Dermatitis—Losartan—type 2 diabetes mellitus	0.000186	0.00175	CcSEcCtD
Chlorzoxazone—Dizziness—Ramipril—type 2 diabetes mellitus	0.000168	0.00157	CcSEcCtD
Chlorzoxazone—Rash—Ramipril—type 2 diabetes mellitus	0.00016	0.0015	CcSEcCtD
Chlorzoxazone—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00016	0.0015	CcSEcCtD
Chlorzoxazone—KCNMA1—liver—type 2 diabetes mellitus	0.000157	0.0431	CbGeAlD
Chlorzoxazone—CYP2A6—liver—type 2 diabetes mellitus	0.000132	0.036	CbGeAlD
Chlorzoxazone—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000112	0.0306	CbGeAlD
Chlorzoxazone—CYP1A1—kidney—type 2 diabetes mellitus	0.000108	0.0295	CbGeAlD
Chlorzoxazone—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000101	0.0275	CbGeAlD
Chlorzoxazone—CYP2E1—kidney—type 2 diabetes mellitus	9.84e-05	0.0269	CbGeAlD
Chlorzoxazone—CYP1A1—adipose tissue—type 2 diabetes mellitus	9.72e-05	0.0266	CbGeAlD
Chlorzoxazone—CYP2E1—cortex of kidney—type 2 diabetes mellitus	9.58e-05	0.0262	CbGeAlD
Chlorzoxazone—CYP3A4—kidney—type 2 diabetes mellitus	7.91e-05	0.0216	CbGeAlD
Chlorzoxazone—CYP2D6—kidney—type 2 diabetes mellitus	7.79e-05	0.0213	CbGeAlD
Chlorzoxazone—CYP1A2—liver—type 2 diabetes mellitus	6.91e-05	0.0189	CbGeAlD
Chlorzoxazone—CYP1A1—liver—type 2 diabetes mellitus	6.82e-05	0.0186	CbGeAlD
Chlorzoxazone—CYP2E1—liver—type 2 diabetes mellitus	6.22e-05	0.017	CbGeAlD
Chlorzoxazone—CYP3A4—liver—type 2 diabetes mellitus	5e-05	0.0137	CbGeAlD
Chlorzoxazone—CYP2D6—liver—type 2 diabetes mellitus	4.92e-05	0.0135	CbGeAlD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	7.94e-06	0.000104	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	7.87e-06	0.000103	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYP3A4—type 2 diabetes mellitus	7.82e-06	0.000102	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GSTM1—type 2 diabetes mellitus	7.78e-06	0.000101	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	7.74e-06	0.000101	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	7.74e-06	0.000101	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—SLC2A4—type 2 diabetes mellitus	7.69e-06	0.0001	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GCG—type 2 diabetes mellitus	7.69e-06	0.0001	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP2E1—type 2 diabetes mellitus	7.65e-06	9.97e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—LPL—type 2 diabetes mellitus	7.63e-06	9.96e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.62e-06	9.94e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.62e-06	9.94e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.62e-06	9.94e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP1A2—type 2 diabetes mellitus	7.56e-06	9.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—SLC2A1—type 2 diabetes mellitus	7.56e-06	9.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	7.48e-06	9.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	7.48e-06	9.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	7.48e-06	9.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	7.48e-06	9.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—ADCY5—type 2 diabetes mellitus	7.47e-06	9.75e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GPX1—type 2 diabetes mellitus	7.45e-06	9.71e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP3A4—type 2 diabetes mellitus	7.37e-06	9.62e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	7.35e-06	9.58e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	7.33e-06	9.57e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.3e-06	9.53e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.3e-06	9.53e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CD36—type 2 diabetes mellitus	7.25e-06	9.46e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GCG—type 2 diabetes mellitus	7.25e-06	9.45e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—SLC2A4—type 2 diabetes mellitus	7.25e-06	9.45e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	7.2e-06	9.39e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	7.2e-06	9.39e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	7.19e-06	9.38e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	7.17e-06	9.36e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PPP2CA—type 2 diabetes mellitus	7.16e-06	9.34e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	7.06e-06	9.21e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	7.03e-06	9.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	7.03e-06	9.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	7.01e-06	9.15e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	7.01e-06	9.15e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	7.01e-06	9.15e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	6.97e-06	9.09e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.97e-06	9.09e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.91e-06	9.01e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—MTHFR—type 2 diabetes mellitus	6.87e-06	8.97e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	6.85e-06	8.93e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.83e-06	8.9e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.79e-06	8.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.79e-06	8.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.79e-06	8.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	6.77e-06	8.83e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.75e-06	8.8e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PPARA—type 2 diabetes mellitus	6.74e-06	8.8e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	6.67e-06	8.7e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	6.63e-06	8.64e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.63e-06	8.64e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	6.6e-06	8.6e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	6.53e-06	8.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	6.51e-06	8.49e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	6.42e-06	8.38e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	6.4e-06	8.35e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.38e-06	8.33e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	6.32e-06	8.25e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	6.32e-06	8.24e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	6.29e-06	8.21e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	6.29e-06	8.21e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	6.29e-06	8.21e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.25e-06	8.15e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GNB3—type 2 diabetes mellitus	6.25e-06	8.15e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	6.22e-06	8.12e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—HMOX1—type 2 diabetes mellitus	6.22e-06	8.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	6.18e-06	8.06e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	6.15e-06	8.02e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CAT—type 2 diabetes mellitus	6.14e-06	8e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	6.12e-06	7.98e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	6.1e-06	7.95e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	6.1e-06	7.95e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	6.03e-06	7.87e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	5.99e-06	7.81e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	5.98e-06	7.8e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.98e-06	7.8e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—APOB—type 2 diabetes mellitus	5.96e-06	7.77e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.94e-06	7.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	5.94e-06	7.75e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	5.94e-06	7.75e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	5.94e-06	7.75e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.91e-06	7.7e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	5.91e-06	7.7e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	5.89e-06	7.68e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	5.8e-06	7.57e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTM1—type 2 diabetes mellitus	5.79e-06	7.56e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.77e-06	7.53e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.77e-06	7.53e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.77e-06	7.53e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.77e-06	7.53e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.75e-06	7.51e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	5.73e-06	7.48e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	5.73e-06	7.48e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.69e-06	7.42e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.69e-06	7.42e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	5.69e-06	7.42e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.66e-06	7.38e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	5.57e-06	7.27e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	5.57e-06	7.26e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.55e-06	7.24e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	5.55e-06	7.24e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.53e-06	7.22e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	5.47e-06	7.13e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.45e-06	7.12e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	5.45e-06	7.12e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	5.43e-06	7.08e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	5.4e-06	7.05e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.35e-06	6.97e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.34e-06	6.96e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	5.33e-06	6.95e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	5.33e-06	6.95e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	5.33e-06	6.95e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	5.33e-06	6.95e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	5.23e-06	6.82e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	5.18e-06	6.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	5.16e-06	6.73e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.15e-06	6.71e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	5.12e-06	6.68e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.11e-06	6.67e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	5.07e-06	6.62e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	5.07e-06	6.62e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	5.06e-06	6.6e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	5.02e-06	6.55e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	5.01e-06	6.54e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	5e-06	6.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.87e-06	6.36e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	4.87e-06	6.35e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.82e-06	6.29e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.8e-06	6.27e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.79e-06	6.25e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	4.79e-06	6.25e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	4.78e-06	6.24e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	4.77e-06	6.22e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	4.71e-06	6.15e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.71e-06	6.14e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.71e-06	6.14e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.7e-06	6.13e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.7e-06	6.13e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.7e-06	6.13e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.68e-06	6.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.68e-06	6.1e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	4.62e-06	6.03e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.62e-06	6.03e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.62e-06	6.02e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.61e-06	6.02e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.59e-06	5.98e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.59e-06	5.98e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.59e-06	5.98e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.56e-06	5.95e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	4.48e-06	5.85e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.48e-06	5.84e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.42e-06	5.77e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	4.4e-06	5.75e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	4.38e-06	5.72e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.36e-06	5.69e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	4.32e-06	5.63e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	4.28e-06	5.58e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	4.19e-06	5.47e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	4.18e-06	5.45e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	4.15e-06	5.42e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.11e-06	5.37e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.11e-06	5.37e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.11e-06	5.37e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	4.07e-06	5.31e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	4.07e-06	5.31e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.04e-06	5.27e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.02e-06	5.24e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4e-06	5.22e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.98e-06	5.2e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.98e-06	5.2e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.96e-06	5.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	3.96e-06	5.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.92e-06	5.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.91e-06	5.1e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.85e-06	5.03e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.8e-06	4.95e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	3.79e-06	4.94e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.79e-06	4.94e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.78e-06	4.93e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.76e-06	4.91e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	3.73e-06	4.87e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.72e-06	4.85e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.72e-06	4.85e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.69e-06	4.82e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.66e-06	4.78e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	3.63e-06	4.73e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.6e-06	4.7e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.59e-06	4.68e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.57e-06	4.66e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	3.57e-06	4.66e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.57e-06	4.65e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.57e-06	4.65e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.55e-06	4.63e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.55e-06	4.63e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.54e-06	4.62e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	3.46e-06	4.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	3.45e-06	4.49e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.4e-06	4.44e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	3.27e-06	4.26e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.26e-06	4.26e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.2e-06	4.18e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.13e-06	4.08e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	3.1e-06	4.05e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.07e-06	4.01e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.07e-06	4.01e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	3.07e-06	4e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.06e-06	3.99e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	3.05e-06	3.98e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	3.04e-06	3.97e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.02e-06	3.94e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	3e-06	3.92e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.93e-06	3.82e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.85e-06	3.72e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.81e-06	3.67e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.8e-06	3.65e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.74e-06	3.57e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.73e-06	3.56e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.69e-06	3.51e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.69e-06	3.51e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.66e-06	3.47e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.65e-06	3.45e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.63e-06	3.43e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.6e-06	3.39e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.52e-06	3.29e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.47e-06	3.22e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.46e-06	3.21e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.39e-06	3.12e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.38e-06	3.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.35e-06	3.07e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.35e-06	3.06e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.32e-06	3.03e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.28e-06	2.97e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.28e-06	2.97e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	2.2e-06	2.87e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.08e-06	2.72e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.04e-06	2.67e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2e-06	2.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.84e-06	2.4e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.76e-06	2.29e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.76e-06	2.29e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.74e-06	2.27e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	1.64e-06	2.14e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.61e-06	2.1e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.24e-06	1.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.05e-06	1.37e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	8.08e-07	1.05e-05	CbGpPWpGaD
